Osteopontin (OPN) is a tumor-associated, secreted phosphoprotein that has been implicated in breast cancer progression and metastasis. Research concerning how OPN functions in tumor progression has led to the identification of a limited number of genes that contribute functionally to OPN-induced cellular behaviors. Recent microarray analysis, comparing 21NT breast cancer cells transfected to constitutively overexpress OPN with control cells, revealed hyaluronan synthase 2 (HAS2) to be a gene highly up-regulated in OPN-overexpressing cells. In this study, we further examined the relationship between OPN and HAS2. We show that 21NT OPN-transfected cells express high levels of HAS2, which is associated with increased HA production and matrix retention and is necessary for tumor cell adhesion to bone marrow endothelial cells and anchorage-independent growth. Finally, stable transfection of antisense HAS2 into 21NT cells overexpressing OPN resulted in a reduction in HAS2 expression, HA production, and pericellular retention. Antisense-mediated down-regulation of HAS2 also resulted in a significant decrease in cellular proliferation and colony growth in soft agar. To our knowledge, this is the first report of the ability of OPN to regulate HAS2 expression and HA production in breast cancer cells and further illustrates a unique functional relationship by which enhanced HA production facilitates OPN-mediated cell behaviors.
The extracellular matrix has a crucial role in tumor development and progression. It provides tumor cells with the necessary scaffold for attachment, migration, and growth and also serves as a reservoir for many growth factors, cytokines, and signaling molecules that may regulate malignant cell behaviors. Further, it provides a contextual three-dimensional microenvironment that contributes to the regulation of cell phenotype (1) .
Osteopontin (OPN)
3 is an extracellular phosphoglycoprotein that has been increasingly implicated in the progression and metastasis of various cancers, including breast cancer. Clinically, OPN has been shown to correlate with disease outcome and patient survival in patients with metastatic breast cancer, as well as in patients with lymph node-negative breast cancer (2) (3) (4) . However, our understanding of the molecular mechanisms by which OPN contributes functionally to malignancy remains poorly understood. OPN is able to bind to cell surface receptors, including integrins and members of the CD44 family. OPNinduced signaling through these receptors has been shown to regulate specific cellular functions including migration, invasion, cell survival, and angiogenesis (5) (6) (7) (8) . The mechanism by which OPN mediates these biological effects has been attributed in part to its ability to regulate the expression of specific genes, although, until recently, only a limited number have been identified (5, 9) .
To identify genes that may contribute to OPN-induced malignant cell behaviors, our group previously performed microarray analysis to compare the expression profiles between 21NT control and OPN-transfected human breast cancer cells (10) . We subsequently categorized those genes differentially regulated by OPN into the six "Hallmarks of Cancer" categories, as defined by Hanahan and Weinberg (11) . Of those genes grouped into the "Tissue Invasion and Metastasis" category, we identified hyaluronan synthase 2 (HAS2) as a gene highly upregulated by OPN.
Hyaluronan (HA) is a linear glycosaminoglycan of repeating disaccharide units of N-acetylglucosamine and D-glucuronic acid. It is found abundantly in the extracellular matrix of various tissues, particularly those undergoing tissue remodeling and rapid cell proliferation (12) . Not surprisingly, increased HA expression has been associated with malignant progression of a variety of tumor types, including breast, prostate, colon, glioma, and mesothelioma (13) . How HA promotes tumor progression is not fully understood but has been suggested to be due to its biomechanical properties, through its ability to expand extracellular spaces to facilitate cell migration. HA may also interact with specific receptors, including CD44 and RHAMM (receptor for hyaluronan-mediated motility), to stimulate adhesion, cell survival, and motility (12) (13) (14) .
HA biosynthesis is catalyzed by multipass transmembrane HAS enzymes. HAS2 is one of three members of the HAS gene family, which also includes HAS1 and HAS3. Each isoform is located on different mammalian chromosomes, yet they have remarkable sequence homology (15) . Although each isoform can catalyze the synthesis of HA, they display different tissue patterns of expression as well as distinct enzymatic characteristics, including their elongation rate of HA and the average size of HA produced (15) . A growing body of evidence suggests that elevated HAS expression can contribute to tumor progression and metastasis. Increased HAS2 expression in fibrosarcoma cells or HAS3 expression in prostate cancer cells leads to enhanced subcutaneous tumor growth in mice (16, 17) . In addition, expression of HAS1 can restore the metastatic potential of mouse mammary carcinoma cells defective in HAS activity (18) . Conversely, targeted down-regulation of HAS2 or HAS3 in prostate cancer cells reduces their ability to adhere to bone marrow endothelial cells, whereas suppression of HAS2 in breast cancer cells inhibits both primary and secondary tumor formation (19, 20) .
In this study, we investigated whether increased HAS2 and HA expression in cells constitutively expressing OPN was necessary for OPN-mediated cell behaviors. Here we show that overexpression of OPN in a tumorigenic human mammary epithelial cell line contributes to increased HAS2 expression and HA production to promote anchorage-independent growth and adhesion to bone marrow endothelial cells. We then show that antisense-mediated down-regulation of HAS2 in these cells results in decreased HAS2 expression, HA secretion, and pericellular matrix retention. Furthermore, antisense inhibition of HAS2 significantly decreases anchorage-independent growth. These results provide the first evidence of a functional relationship between OPN and HAS2 in the malignancy of breast cancer.
EXPERIMENTAL PROCEDURES
Cell Culture-The NTOPbi (OPN-transfected) and NTCi (mock transfected) cell lines were cultured in standard growth medium (␣HE ϩ 10% fetal bovine serum ϩ 200 g/ml G418) as described previously (10) . These cells were previously derived from the 21NT tumorigenic, nonmetastatic human mammary carcinoma cell line (21) by stable transfection with either a pcDNA3 vector containing a full-length human OPN cDNA (21NTOPbi) or an unmodified pcDNA3 expression vector (21NTCi) (5) . Transfection of OPN into the 21NT cells resulted in an 8.1-8.6-fold increase in OPN mRNA and protein expression, respectively, relative to mock transfected cells (5, 22) . Relative to the highly metastatic MDA-MB-435 cell line, which is known to naturally express very high levels of OPN, 21NTOPbi cells expressed 67% of the levels of OPN protein in conditioned media (12 ng/ml versus 17.9 ng/ml by ELISA assay), whereas the control cells expressed only 7.8% of the amount of OPN (1.4 ng/ml versus 17.9 ng/ml) (data not shown). The human bone marrow endothelial cell line, hBMEC UEAP P 03 , was obtained as a kind gift from Dr. Ken Pienta (University of Michigan School of Medicine, Ann Arbor, MI). These cells were previously transformed with the SV40 virus to maintain a stable cell line and were grown in Dulbecco's modified Eagle's medium with high glucose ϩ 10% fetal bovine serum. All of the cells were maintained at 37°C in a 5% CO 2 incubator.
Quantification of HAS and OPN Messenger RNA Expression-OPN and HAS isoform expression was quantified by real time PCR using gene-specific primers. Total RNA was extracted from subconfluent plates using TRIzol reagent (Invitrogen) according to the protocol supplied by the manufacturer. RNA concentration was determined by absorbance at 260 nm by standard spectrophotometric analysis, and RNA samples were frozen at Ϫ80°C. 0.5 g of RNA was used to prepare a 20-l reaction volume of cDNA in a first strand cDNA synthesis reaction using SuperScript II RT (Invitrogen) and random hexamers. Quantitative detection and analysis of mRNA gene expression was performed using the Stratagene Mx3000P real time RT-PCR system with SYBR Green chemistry (Stratagene, La Jolla, CA). Real time RT-PCR primers were designed using PrimerQuest software (scitools.idtdna.com/Primerquest/) and synthesized by Sigma-Genosys (Oakville, Canada). Primer sequences were as follows: OPN forward, 5Ј-AGTTTCGCAGACCTGACATC-CAGT, and reverse, 5Ј-TTCATAACTGTCCTTCCCACG-GCT; ␤-actin forward, 5Ј-GGAAATCGTGCGTGACATTA, and reverse, 5Ј-GGAGCAATGATCTTGATCTTC; HAS1 forward, 5Ј-CGATACTGGGTAGCCTTCAATG, and reverse: 5Ј-GGAGGTGTACTTGGTAGCATAACC; HAS2 forward, 5Ј-CACACTCTTTGGAGTCTCTCTC, and reverse, 5Ј-GGTCAT-CTTCTGAGTTCCCATC; and HAS3 forward, 5Ј-AACTAAG-TATACCGCGCGCTCCAA, and reverse, 5Ј-AGGTGGTGC-TTATGGAACCACAGA. The primers were reconstituted to a concentration of 6 ϫ 10 Ϫ5 mol/l in sterile TE buffer (10 mM Tris-Cl, 1 mM EDTA), pH 8.0, and further diluted 1:10 in sterile water prior to the assay. PCRs were set up according to the manufacturer's instructions provided with the Brilliant SYBR Green QPCR Master Mix kit (Stratagene). All of the reactions were carried out in a final volume of 25 l and consisted of 12.5 l of 2ϫ Brilliant SYBR Green QPCR Master Mix, 30 nM final concentration of the passive reference dye, 25 ng cDNA, and 6 ϫ 10 Ϫ6 mol/l forward and reverse primers. OPN and ␤-actin primers were used at final concentrations of 100 nM, and HAS1, HAS2, and HAS3 primers were used at final concentrations of 150 nM. All of the samples were run in triplicate, in parallel with no template controls for each gene analyzed. The standard amplification protocol consisted of a 10-min incubation at 95°C followed by 40 amplification cycles at 95°C for 30 s, 60°C for 1 min, and 72°C for 1 min. Fluorescent measurements were taken at the end of the 72°C extension step. Cycle threshold, the cycle at which fluorescence is determined to be statistically significant above background, was set within the linear range for all reactions. To determine the efficiency of the reaction and purity of the products, a melt curve analysis was performed at the end of each reaction by incubating the samples at 95°C for 1 min and ramping down to 55°C at a rate of 0.2°C/s. This was followed by a stepwise increase in temperature from 55 to 95°C for 81 cycles, in which the temperature was increased by 0.5°C/cycle (30 s/cycle), with fluorescent measurements taken at each temperature increment. Standard curves for each gene were generated by serially diluting known amounts of cDNA. All of the amplifications were carried out within the linear range of the standard curves. Expression analysis and calculation of relative changes in gene expression were determined using Stratagene Mx3000Pro software. The relative expression levels were calculated by first normalizing the expression of the gene of interest to the ␤-actin expression level followed by taking the ratio of the normalized OPN-transfected cell value to the normalized vector-transfected control cell level.
Particle Exclusion Assay-Pericellular matrices were visualized by the particle exclusion assay, as described previously (23) . Briefly, 1.5 ϫ 10 4 cells were plated on 35-mm culture dishes in triplicate in standard culture medium and allowed to adhere overnight. The following day, culture medium was aspirated, and the cells were pretreated in the presence or absence of Streptomyces hyaluronidase (Sigma-Aldrich) (16 units/ml in serum-free medium containing 0.1% bovine serum albumin) for 20 min at 37°C. The medium was removed, and 1.0 ϫ 10 8 cells/ml of gluteraldehyde-fixed sheep erythrocytes (Accurate Chemical & Scientific Corp.) in phosphate-buffered saline with 0.1% bovine serum albumin were added to each culture dish and allowed to settle for 10 min at room temperature. The cells were then viewed on a Nikon TE300 phase contrast microscope with Hoffman optics at 400ϫ magnification. Pericellular matrices were seen as halos surrounding the cell from which the fixed erythrocytes were excluded. To quantify the amount of matrix production, 20 -30 randomly selected cells were photographed, and the cell coats (matrix) and cell areas were traced using Image ProPlus 5.1 image software. The ratio of the matrix to cell area was used as an indicator of HA matrix thickness. A ratio of 1.0 indicates an absence of an organized pericellular matrix.
Quantification of HA Synthesis-The concentration of HA in cell culture supernatants was determined in a competitive ELISA assay purchased from Echelon Biosciences Incorporated (product number K-1200; Salt Lake City, UT). The cells were plated in triplicate in 100-mm tissue culture dishes and allowed to grow to ϳ80% confluence. The cells were then washed twice with serum-free medium (␣HE ϩ 0.1% bovine serum albumin). Fresh serum-free medium was added to each plate and incubated overnight at 37°C. The following day, the conditioned medium was removed from each plate, centrifuged to remove any floating debris, and frozen at Ϫ80°C. The cell counts were determined by trypsinization and counting in a hemacytometer. All of the samples were examined in triplicate according to the manufacturer's instructions. The plates were read at 405 nm, and the percentage of binding was calculated for each sample. HA concentrations were determined by comparing the percentage of binding to a standard curve of binding at known HA concentrations. The mean HA concentration for each sample was calculated and normalized to cell number. The concentrations are expressed in ng/ml/10 6 cells. Anchorage-independent Growth Assay-Quadruplicate plates were first layered with 2 ml of a 1:1 mixture of 1.0% agarose solution with ␣HE ϩ 10% fetal bovine serum containing the appropriate selective agent (either 200 g/ml G418 (active) or 200 g/ml G418 plus 500 g/ml hygromycin for antisense transfectants) and allowed to solidify for 1 h in a laminar flow hood. The cells were harvested by trypsinization and resuspended to a final concentration of 2.0 ϫ 10 5 cells/ml. The top layer consisted of a 1:1 mixture of 0.6% agarose with ␣HE ϩ 10% fetal bovine serum medium containing the appropriate selective agent and 1.0 ϫ 10 4 cells, which was overlaid on the preprepared bottom layer and allowed to solidify for ϳ15 min at room temperature. The plates were then incubated in a 37°C incubator for 1 h, after which 3 ml of standard growth medium was added to each plate. The cells were allowed to grow for 3-4 weeks with fresh medium added every 3 days. To study the role of HA, activityblocking HA oligosaccharides (o-HA) (24) were obtained as a kind gift of Dr. Bryan P. Toole (Tufts University School of Medicine, Boston, MA). The cells were preincubated with 100 g/ml HA oligomers for 30 min and then suspended 1:1 in 0.3% agarose with a final oligomer concentration of 100 g/ml and allowed to grow undisturbed for 12 days. At the end of the incubation periods for all experiments, the cells were fixed overnight in 10% formalin and replaced with phosphate-buffered saline. Colonies greater than 150 m were counted for each cell line across the entire plate. Statistical differences between the groups were determined with the Student's t test using Sigma Stat software. All of the experiments were performed three times with similar results.
Bone Marrow Endothelial Cell Adhesion Assay-21NT control (NTCi) and OPN-transfected cells (NTOPbi) were plated in 150-mm culture dishes in standard growth medium and grown to ϳ80% confluence. Human bone marrow endothelial cells (BMECs) were plated at 4.5 ϫ 10 4 cells/well on 48-well plates 1 day prior to the assay and allowed to grow to confluence overnight. Subconfluent 21NT-derived cells were labeled in 0.5 nM Cell Tracker Green CMFDA (Molecular Probes, Burlington, Canada), diluted in adhesion medium (␣HE ϩ 0.1% bovine serum albumin) for 30 min, followed by a 30-min incubation in standard growth medium. The cells were then trypsinized, washed in adhesion medium, and resuspended to a final concentration of 1.0 ϫ 10 5 cells/ml. The cells were incubated with or without the presence of 16 units/ml Streptomyces hyaluronidase (Sigma) for 25 min at 37°C with gentle agitation. The hyaluronidase was present throughout the duration of the assay. BMECs were washed twice with adhesion medium, and 300 l of tumor cells were added and allowed to adhere for 20 min at 37°C. Nonadherent cells were removed by washing twice with 500 l of adhesion medium. The adherent cells were solubilized in 500 l of phosphate-buffered saline containing 1% SDS and 0.2 M NaOH, and fluorescence was measured in a Victor fluorescence plate reader (PerkinElmer Life Sciences) at 485 and 530 nm. All of the experiments were performed three times with similar results.
Preparation of Stable Antisense HAS2 Transfectants-HAS2 antisense (asHAS2) and vector control (VC) plasmid constructs were a kind gift of Dr. James B. McCarthy (University of Minnesota, Minneapolis, MN). Plasmid constructs were made using the pIRES-Hyg vector (Clontech) (19) . For the HAS2 antisense constructs, the first 300 base pairs of the HAS2 sequence, including the ATG start codon, was amplified from HAS2 plasmid DNA and cloned in the antisense orientation into pIRESHyg. 21NT OPN-transfected cells were transfected with FuGENE transfection regent (Roche Applied Science) in serum-free medium according to the manufacturer's instruc-tions. The cells were allowed to recover in standard culture medium without antibiotics for 48 h, subcultured onto 100-mm dishes, and allowed to grow for an additional 48 h. Growth medium was then replaced with selective medium containing hygromycin (0.5 mg/ml, active) and geneticin (0.2 mg/ml, active), and clones were allowed to establish colonies. The clonal colonies were picked using cloning rings. Stable transfected cell lines were established by screening antibiotic resistant colonies. Down-regulation of HAS2 in the antisense HAS2-transfected cell line (asHAS2) was confirmed by real time PCR analysis of OPN and HAS2 expression, HA ELISA, and particle exclusion as described above and compared with vector-transfected cell line (VC). The selective growth medium was maintained in all routine culturing and experiments except where stated. Cellular morphology was comparable among all of the experimental groups.
Cell Proliferation Assay-Exponentially growing cells were plated in triplicate onto the wells of a 6-well plate (2.3 ϫ 10 4 cells/well). The cells were trypsinized, and cell number was determined using a hemacytometer on every second or third day of an 11-day growth period.
RESULTS

OPN Overexpression Results in Increased HAS2
Expression-Previously, our group performed microarray analysis on 21NT control versus 21NT OPN-transfected cells to identify genes differentially regulated by OPN (10) . Among those genes up-regulated by OPN was the gene encoding HAS2, whose expression we confirmed by real time PCR analysis. Because HAS2 is one of three isoforms of the HAS gene family, we wished to profile the expression of all three isoforms to determine the expression patterning of these isoforms in the 21NT cells. Real time PCR analysis verified that HAS2 is indeed the most highly up-regulated isoform in the 21NT OPN-transfected cells, with an approximate 6-fold increase in expression relative to control cells (Fig. 1A) . This result is consistent with our microarray data, which revealed a 5.8-fold increase in HAS2 expression. Although HAS3 expression was detected in both cell lines by real time PCR, there was no observable difference between them. HAS1 expression levels were barely detectable.
OPN Overexpression Leads to Enhanced HA Production and Abnormal Accumulation of HA Matrix-To confirm that increased HAS2 expression correlated with enhanced HA production, we used a quantitative ELISA to measure the amount of secreted HA by the 21NT cell lines. 21NT OPN-transfected cells produced significantly more HA compared with their controls (Fig. 1B) , secreting an average of ϳ530 ng of HA/10 6 cells/day.
Because pericellular HA has been shown to play an important role in malignant progression, we used a method of particle exclusion to visualize the matrix production and retention by the 21NT cells. In this assay, the cells are preincubated with a solution of fixed sheep erythrocytes (particles), which, based on the charge and size of HA, are excluded from the matrix surrounding a cell. Matrices are visualized by clear areas surrounding a cell. We observed significantly larger pericellular coats in the 21NT OPN-transfected cells, with a greater than 2-fold increase in matrix production compared with controls that did not form pericellular coats (Fig. 2) . To confirm that these matrices were composed of HA, we pretreated the cells with Streptomyces hyaluronidase, specific for HA, prior to the addition of particles. Hyaluronidase treatment completely abolished matrix assembly by the 21NT OPN-transfected cells, thereby confirming HA composition and indicating that these cells can assemble their secreted HA into a functional matrix (Fig. 2) .
These results, revealing enhanced production of secreted HA and cell-associated HA in the OPN-transfected cells, were independently confirmed using fluorophore-assisted carbohydrate electrophoresis (25) , further verifying elevated HA production in these cells (data not shown).
Increased HA Production Contributes to Enhanced Anchorage-independent Growth of 21NT OPN-transfected Cells-Anchorage-independent growth is a hallmark of tumorigenic potential, particularly of epithelial cells. Various studies have shown that elevated levels of HAS2, and therefore HA, strongly promote anchorage-independent growth of tumor cells in vitro white bars) using the Stratagene Mx3000 real time PCR system. Total RNA was reverse transcribed, and standard curves for each gene were generated by serial cDNA dilutions. ␤-Actin was amplified as a control for input RNA quantities and used for normalization of expression for each cell line. The data are the means of triplicate samples Ϯ S.E. B, validation of HA production in 21NT cells. HA ELISA analysis was used to determine the level of HA production in the 21NT control transfected cells (NTCi; white bar) and 21NT OPN-transfected cells (NTOPbi; black bar). 21NT cells were plated and allowed to grow to semiconfluency, after which cells were starved overnight in serum-free medium. The conditioned medium was used in a competitive binding assay to determine the level of HA synthesis as described under "Experimental Procedures." HA concentrations were normalized to 10 6 cells and are plotted as average HA concentration (ng/ml)/10 6 cells Ϯ S.E. (16) . These studies suggest that the increased levels of HA observed in the 21NT OPN-transfected cells might support the growth of these cells in soft agar. To examine this hypothesis, we first grew 21NT control and OPN-transfected cells in soft agar and compared their ability to form colonies. In accordance with their levels of pericellular HA, we found that the OPNtransfected cells consistently formed larger and more numerous colonies, compared with control transfected cells, which failed to form colonies in soft agar (Fig. 3, A, B, and D) .
To determine whether the enhanced growth potential of the 21NT OPN-transfected cells was mediated by HA, we then cultured 21NT OPN-transfected cells in soft agar in the presence or absence of HA oligosaccharides. These HA oligomers, composed of 3-10 disaccharide units, are thought to replace high affinity, multivalent receptor interactions with low affinity, low valency interactions, therefore interfering with the activity of endogenously produced HA (26) . Treatment of 21NT OPNtransfected cells with 100 g/ml HA oligomers in soft agar significantly decreased colony formation by almost 2-fold (Fig. 3,  C and D) .
Elevated Levels of HA Promote Increased Binding of 21NT OPNtransfected Cells to Bone Marrow
Endothelial Cells-HA has been shown to mediate the adhesion of breast and prostate cancer cells to BMECs, suggesting a role for HA in promoting metastasis to the bone. We first tested the ability of 21NT control and OPN-transfected cells to bind to BMECs and found that 21NT cells overexpressing OPN bound better compared with control cells (Fig. 4) . To determine whether this interaction is dependent on surface HA retention, 21NTCi and 21NTOPbi cells were pretreated with or without hyaluronidase (HAase) and then allowed to adhere to BMECs. Pretreatment with HAase significantly reduced adhesion of 21NT OPN-transfected cells to BMECs, whereas control cells showed little change in their ability to bind following HAase pretreatment, indicating a direct role for increased HA production in promoting this cellular behavior.
Antisense Down-regulation of HAS2 Results in Decreased HAS2 mRNA Expression-To determine the effect of down-regulation of HAS2 in the OPN-transfected cells, we generated two stably transfected cell lines from the 21NT OPNtransfected cells: NTOP/VC, vector-transfected control, and NTOP/ asHAS2, HAS2 antisense-transfected cell line. Real time PCR analysis revealed a significant down-regulation in HAS2 mRNA expression in the NTOP/ asHAS2 cells, whereas HAS2 expression in the vector-transfected control cell line was unchanged from the parental untransfected cells (Fig. 5A) . To confirm that the reduced HAS2 mRNA levels in the antisense-transfected cells were not due to a lower level of OPN, we examined OPN expression and found no reduction in expression in the asHAS2 cells but rather found a significant increase in expression of OPN in the HAS2 antisense transfectants (Fig. 5B) .
HAS2 Inhibition Results in Diminished HA Production and Retention-We next evaluated whether antisense down-regulation of HAS2 altered HA production. To quantify levels of secreted HA, we again used an HA ELISA approach, which revealed comparable levels of liberated HA between the 21NT OPN-overexpressing cell line transfected with control vector and the parental OPN-transfected cells (i.e. NTOP/VC versus NTOPbi) (Fig. 6A) . However, 21NT OPN-overexpressing HAS2 antisense transfectants (NTOP/asHAS2) produced significantly less HA. Next, we examined pericellular matrix pro- duction by particle exclusion as described above. As shown in Fig. 6B , antisense inhibition of HAS2 significantly reduced the thickness of the pericellular coats, with an ϳ2-fold, but not complete, reduction compared with parental untransfected controls (i.e. NTOP/asHAS2 versus NTOPbi). No appreciable difference in cell-associated HA levels was observed between vector control and parental cell lines (i.e. NTOPbi versus NTOP/VC). The reduction in secreted HA and pericellular matrix distribution by the antisense HAS2 transfectants are thus in strong agreement with the reduced levels of HAS2 mRNA in these cells.
Antisense Down-regulation of HAS2 Results in Reduced Cell Proliferation-The in vitro growth rates of the transfected cell lines were examined over an 11-day period. Whereas there was a comparable growth pattern by the 21NT OPN-overexpressing parental cells (NTOPbi) and vector-control transfected control cells (NTOP/VC), the antisense HAS2 transfected cells (NTOP/asHAS2) exhibited significantly reduced cell proliferation (Fig. 7A) .
Suppression of HAS2 Reduces Anchorage-independent Growth Ability of 21NT OPN-overexpressing Cells-To determine whether the reduction in HAS2 expression was functionally important for an OPN-mediated phenotype, we evaluated the growth of the HAS2 antisensetransfected cells in soft agar. Antisense down-regulation of HAS2 in the OPN-transfected cells (NTOP/ asHAS2) resulted in a dramatic decrease in the anchorage-independent growth potential of these cells in soft agar compared with parental (NTOPbi) and control vectortransfected cell lines (NTOP/VC) (Fig. 7B) .
DISCUSSION
OPN is a secreted phosphoprotein that has been increasingly recognized as an important contributor to the progression of various human cancers. However, the specific mechanisms by which OPN functions to promote malignant cell behavior have not been completely elucidated. In this study, we have shown that endogenous overexpression of OPN in the 21NT tumorigenic breast cancer cell line results in increased HAS2 expression and HA production. The elevated production of HA in these cells contributed to enhanced anchorage-independent growth and adhesion to BMECs. Furthermore, targeted down-regulation of HAS2 in 21NT OPN-overexpressing cells led to a significant reduction in HA production and cell surface retention, and a dramatic decrease in their growth potential in twodimensional culture and in soft agar. Up-regulation of HAS2, and hence HA, therefore represents a novel mechanism by which OPN may promote malignant behavior in breast cancer.
Overexpression of HA, as a result of elevated HAS2 expression, has been documented to have a functional role in the malignant and metastatic phenotypes of various tumor types, including breast (27) and prostate (28) . Increased HAS2 expression has been shown to contribute to enhanced cell survival and anchorage-independent growth of human HT1080 fibrosarcoma (16) and mesothelioma cells (29) and to increase the tumorigenic capacity of malignant mesothelioma (29) and breast cancer cells (20) . Our finding that cells overexpressing OPN also up-regulate HAS2 expression is thus in accordance with such previous reports in which enhanced HAS2 expression correlates with increased malignant behavior.
The ability of breast cancer cells overexpressing OPN to bind to BMECs is a novel finding, yet adds to the growing evidence for a role of OPN in contributing to the development of bone metastasis (30) . For example, OPN has previously been identified as part of a gene set whose combined overexpression is required for osteolytic metastasis formation, whereas downregulation of OPN in MDA-MB-231 human breast cancer cells by antisense has been shown to reduce metastatic lesions in the bone (31, 32) . Our data showing that adhesion of OPN-overexpressing cells is mediated by increased production of cell surface HA provides a mechanistic explanation that is also consistent with similar studies examining the role of HA in tumor cell-BMEC adhesion.
Cell surface HA, as a result of increased HAS expression, HA synthesis, and HA retention, has already been shown to mediate adhesion of circulating prostate and breast cancer cells to BMECs, and in some cases, this interaction has been shown to be mediated in part by CD44 (19, 33) . It is worth noting that both the BMECs used in our study and 21NT OPN-overexpressing cells strongly express cell surface CD44, the principal receptor for HA and one of the primary receptors for OPN (34) . This suggests a potential integrative binding mechanism by which breast cancer cells co-expressing OPN and HA present these ligands via CD44 to CD44 receptors present on the surface of BMECs. How each of these factors play a role in the adhesion of breast cancer cells to BMECs in this model is currently under investigation. Because removal of the HA coat retained by OPN-transfected cells did not completely reduce adhesion to the level of control cells, our data suggest that other binding partners regulated by OPN may also be involved in the 21NT tumor cell-BMEC adhesion process.
In addition to promoting tumor cell adhesion, our results also show that cells overexpressing OPN have enhanced ability to grow in soft agar compared with controls and that manipulation of cell surface HA by short chain HA oligomers disrupts this phenotype. The ability of tumor cells to grow in an anchorage-independent fashion has been demonstrated to involve the activation of the phosphoinositide 3,4,5-trisphosphate/Akt cell survival signaling pathway. OPN is able to induce the anchorage independence of breast tumor cells (35) and to promote antiapoptotic signaling through phosphorylation of phosphoinositide 3,4,5-trisphosphate and Akt activation (7) . Conversely, Akt kinase can induce OPN expression to promote colony formation in soft agar (36) . Our results suggest that these effects of OPN in promoting cell survival and growth in anchorage-independent conditions involve HA.
Expression of HA itself has also been shown to promote the anchorage-independent growth potential of various cancer cell models. Furthermore, HA oligomers, known to displace endogenously produced HA from CD44 or other HA-binding receptors, have been demonstrated to function through the Akt pathway to activate specific pro-apoptotic mediators and the effector molecule, caspase-3 (26) . The requirement for HA in the cell survival and anchorage-independent growth ability of breast cancer cells constitutively overexpressing OPN therefore further supports a central role for HA in these properties. Our data may also indirectly implicate CD44 as the primary mediator of these effects, given its role in intracellular cascades to activate Akt and its ability to bind both OPN and HA ligands.
To determine the functional contribution of elevated HAS2 expression in cells constitutively overexpressing OPN, we employed a vector-mediated antisense approach to target HAS2 for gene-specific silencing. Our results show that the antisense down-regulation of HAS2 results in a significant yet partial decrease in HAS2 mRNA expression. This led to a significant but incomplete reduction in HA production and matrix retention, likely reflected by the inability to fully knock down the HAS2 message or by residual HA production by the remaining HAS isoforms. The difficulty in obtaining complete HAS knockdown by antisense has been demonstrated by other groups, and in some studies, only in double antisense HASinhibited cancer cells was there a complete reduction in HAS levels as compared with base-line levels (19) . As well, the incomplete knockdown of HA production observed in our study is unlikely due to compensation effects by HAS1 or HAS3 isoforms, because no change in expression of these isoforms has FIGURE 6. HA production by antisense HAS2-transfected cells. A, quantification of liberated HA. HA ELISA was used to measure secreted HA from conditioned medium from each cell line as described under "Experimental Procedures." HA synthesis is expressed as ng/ml/10 6 cells from triplicate experiments. B, quantification of matrix production by particle exclusion. Surface HA retention was determined by particle exclusion from at least 30 randomly selected cells for each stably transfected cell line. Coat/cell area ratios are presented as the means Ϯ S.E. White solid bars, 21NT control (NTCi); black solid bars, OPN-transfected (NTOPbi); black hatched bars, 21NT OPN vectortransfected control (NTOP/VC); white hatched bars, 21NT OPN asHAS2-transfected cells (NTOP/asHAS2). previously been shown in studies using antisense approaches to knock down HAS2, either in prostate or breast cancer cell models (19, 20) . In any event, the dramatic reduction in three-dimensional colony growth we have seen in the asHAS2 transfected cells suggests that any such compensatory effect was functionally negligible.
Antisense-mediated suppression of HAS2 was also shown to have a dramatic inhibitory effect on the cellular proliferation and anchorage-independent growth ability of 21NT OPNtransfected cells. These observations are in strong agreement with a recent study by Udabage et al. (20) , who reported complete inhibition of primary tumor formation and metastasis of MDA-MB-231 breast cancer cells following antisense inhibition of HAS2. These effects could be attributed to reduced in vitro cell proliferation and reduction in the percentage of cells in the S phase of the cell cycle, results that are paralleled in a study on the effect of HAS2 in epidermal keratinocytes (37) . Other studies, however, have suggested that HAS2 plays a crucial role in the G 2 M transition of the cell cycle (38) . Further examination of the cell cycle profile of these cells should help clarify how HAS2 is functioning to produce such an effect on growth.
In conclusion, enhanced synthesis of HA by HAS2 appears to be an important molecular alteration in breast cancer cells constitutively overexpressing OPN, influencing cell properties important both at the primary tumor site, by enhancing cell proliferation and survival, and at the secondary metastatic site such as the bone, in terms of promoting enhanced adhesion to BMECs. Interfering with HA synthesis or its interaction with HA receptors such as CD44 may thus provide a novel target(s) for therapeutic strategies designed to block OPN-associated malignancy.
